Psychedelicalpha

Published October 8, 2026 · Updated October 9, 2026

Pα+ Psychedelic Bulletin #233: FDA Floats Ibogaine Trial Design; Compass Talks Pricing

Read the full story at Psychedelicalpha

FDA Floats Ibogaine Trial Design, Asks Field for Input • Compass Talks Pricing, Label and a Slow Launch • Six More Potential Psychedelic Brand.